Cargando…
Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response
Basal cell carcinoma (BCC) is the most common form of skin cancer, affecting more often elderly patients, but sometimes even younger ones, particularly if immunocompromised or genetically predisposed. Specifically, the Gorlin-Goltz syndrome, an autosomal dominant genodermatosis, also known as nevoid...
Autores principales: | Gambini, Donatella, Passoni, Emanuela, Nazzaro, Gianluca, Beltramini, Giada, Tomasello, Gianluca, Ghidini, Michele, Kuhn, Elisabetta, Garrone, Ornella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237470/ https://www.ncbi.nlm.nih.gov/pubmed/35775005 http://dx.doi.org/10.3389/fmed.2022.893063 |
Ejemplares similares
-
Sonidegib in Locally Advanced Basal Cell Carcinoma: A Monocentric Retrospective Experience and a Review of Published Real-Life Data
por: Nazzaro, Gianluca, et al.
Publicado: (2023) -
Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center
por: Denaro, Nerina, et al.
Publicado: (2023) -
Immune checkpoint inhibitor therapy for hepatocellular carcinoma
por: Ramai, Daryl, et al.
Publicado: (2022) -
Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience
por: Denaro, Nerina, et al.
Publicado: (2022) -
Ultrasonographic diagnosis of erythema nodosum
por: Nazzaro, Gianluca, et al.
Publicado: (2021)